Write a short note on Fibroadenoma.

The Concept

A fibroadenoma is the commonest benign breast tumour and the commonest breast lump in young women (15–30 years). It is best understood not as a true neoplasm but as an aberration of normal development (ANDI) — a single breast lobule overgrows, producing a well-defined lump made of both glandular (adeno) and fibrous (fibro) tissue. Because it is hormone-responsive, it tends to grow in pregnancy and regress after menopause.

Clinical Features

It presents as a painless, smooth, firm, rubbery, well-circumscribed lump that is remarkably mobile under the examining finger — earning the classic name 'breast mouse'. It is usually solitary and 1–3 cm. This very high mobility (because it is not fixed to surrounding tissue) is a reassuring clinical feature, though it can never substitute for formal assessment.

Investigation & Management

Diagnosis is confirmed by triple assessment — clinical examination, ultrasound (the imaging of choice in this young, dense-breasted age group), and core biopsy. Once confirmed as a fibroadenoma, management is often conservative — reassurance and observation — because malignant change is very rare. Excision is offered if the lump is large (> 3–4 cm), growing, symptomatic, or the patient wishes it removed, or if there is any diagnostic doubt. A 'giant' fibroadenoma (in adolescents) and the rarer phyllodes tumour (which can recur/be malignant and needs wide excision) are important variants to distinguish.

Variants & Course

Two variants matter. A giant fibroadenoma (> 5 cm, often in adolescents or during pregnancy) grows large and may need excision for size alone. The phyllodes tumour can look identical clinically but is more cellular, tends to recur and has malignant potential — so it must be distinguished on biopsy. The natural history of an ordinary fibroadenoma is benign: about a third regress, a third stay the same and a third slowly enlarge, which is why observation is reasonable once the diagnosis is secure.

Exam Pointer

For the viva, anchor the answer on the single defining idea and its safe rule: state the mechanism, the classic clinical picture, the mandatory role of triple assessment where a lump or discharge is involved, and the specific management — and be ready to contrast the condition with the malignancy it can mimic, since that contrast is what examiners most often probe.

Management & Counselling

Once triple assessment confirms a fibroadenoma, management is a shared decision. Many women, reassured that it is benign with negligible malignant potential, opt for observation; others prefer excision for peace of mind or if the lump is large, growing or symptomatic. Excision options include conventional surgery or, for suitable lesions, vacuum-assisted excision. The clinician also explains the natural history — that many fibroadenomas remain stable or regress — so the choice to observe is made with confidence rather than anxiety, while any change prompts re-assessment.

Highly mobile, firm and painless in a young woman is characteristic.

• Commonest benign breast tumour; young women (15–30); an ANDI (overgrowth of a single lobule), hormone-responsive.
• Painless, smooth, firm, very mobile 'breast mouse'; usually solitary, 1–3 cm.
• Confirm by triple assessment (ultrasound + core biopsy in this age group).
• Conservative (reassure/observe) as malignancy is rare; excise if large/growing/symptomatic or doubt.
• Distinguish from phyllodes tumour (needs wide excision — recurrence/malignant potential).